The UBS CIO Americas wealth management equity sector strategy team came out and spotlighted its 30 most preferred stocks ...

DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose ...

Discussions at the Advanced Technologies & Treatments for Diabetes meeting covered CGM use in non–insulin-treated people with ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...

The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

DexCom Inc. closed 48.20% below its 52-week high of $142.00, which the company reached on March 26th.

According to Bloomberg's Apple expert Mark Gurman, the new and upgraded health features are part of what is being called ...

Dexcom (Nasdaq:DXCM) has a new chief commercial officer with significant experience at another major medtech company.

DexCom Inc. closed 46.96% short of its 52-week high of $142.00, which the company achieved on March 26th.

They should have won another rollercoaster in the seasonal opener at Thomond Park, whereas here Munster were the better team ...